Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 611

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

Open access
Garcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., Sedlackova, E., Toumpanakis, C., Anlauf, M., Cwikla, J.B., Caplin, M., O''Toole, D., Perren, A., all other Vienna Consensus Conference participants · 2016 · Neuroendocrinology

Abstract

are not a homogenous entity and can be further subclassified into biologically relevant subgroups.A separation based on the proliferative index (Ki-67 >55%) was shown to have clinical implications regarding response to chemotherapy and prognosis: NEC with Ki-67 >55% responded better to platinum-based chemotherapy and, nevertheless, had a 4 months' shorter median survival than G3 NEN in the lower proliferative range (20-55%) [1] .More recent publications show that morphological differentiation and Ki-67 are able to separate prognostic groups among G3 cases, and therefore a separation of well-differentiated G3 NET from poorly differentiated G3 NEC is emerging [2][3][4] .The exact criteria need to be defined both on the morphological and on the molecular level.The spectrum of mutations of well-differentiated

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000443172

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 611

Metadata

Authors
Garcia-Carbonero, R., Sorbye, H., Baudin, E., Raymond, E., Wiedenmann, B., Niederle, B., Sedlackova, E., Toumpanakis, C., Anlauf, M., Cwikla, J. B., Caplin, M., O''Toole, D., Perren, A., & participants, A. O. V. C. C.
Venue
Neuroendocrinology
Publisher
S. Karger AG
Published
2016
Volume
103
Issue
2
Pages
186-194
ISSN
  • 0028-3835 (ISSN-L)
  • 1423-0194
OpenAlex
W2227093581
Cited by
611
References
37
FWCI
44.98
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.